The FDA has approved the first blood test for Alzheimer's, allowing for earlier treatment with existing drugs. This innovative test measures protein ratios linked to the disease, promising better patient outcomes.
A recent survey reveals that older Americans are increasingly proactive about Alzheimer's, with 79% wanting to know if they have the disease before symptoms arise. Many would opt for a blood test and are open to new drug treatments.
A groundbreaking urine test for prostate cancer has shown remarkable accuracy, outperforming traditional blood tests. Set to enter clinical trials, this innovation may make routine screenings a reality, potentially saving thousands of lives.
A new blood test developed by neuroscientists can reveal whether Alzheimer's is affecting a patient's memory, providing crucial insights for early diagnosis and treatment. This innovation could transform how we understand and address Alzheimer's disease.
Every Wednesday, cancer experts at Cleveland Clinic discuss the shocking surge of colorectal cancer in young people. Discover the alarming facts, symptoms, and what can be done to stop this epidemic.
